Inhaled GM-CSF was offered to 3 patients with alveolar proteinosis superimposed with unclassifiable pulmonary fibrosis: 1 with MARS mutation and 2 brothers without any identified known mutation. This evidence concerns the gene CSF2 and Intraalveolar phospholipid accumulation.